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We sought to create a screening tool with improved predictive value for pediatric severe
sepsis (SS) and septic shock that can be incorporated into the electronic medical record
and actively screen all patients arriving at a pediatric emergency department (ED). “Gold
standard” SS cases were identified using a combination of coded discharge diagnosis
and physician chart review from 7,402 children who visited a pediatric ED over 2 months.
The tool’s identification of SS was initially based on International Consensus Conference
on Pediatric Sepsis (ICCPS) parameters that were refined by an iterative, virtual process
that allowed us to propose successive changes in sepsis detection parameters in order
to optimize the tool’s predictive value based on receiver operating characteristics (ROC).
Age-specific normal and abnormal values for heart rate (HR) and respiratory rate (RR) were
empirically derived from 143,603 children seen in a second pediatric ED over 3 years. Uni-
variate analyses were performed for each measure in the tool to assess its association
with SS and to characterize it as an “early” or “late” indicator of SS. A split-sample was
used to validate the final, optimized tool.The final tool incorporated age-specific thresholds
for abnormal HR and RR and employed a linear temperature correction for each cate-
gory. The final tool’s positive predictive value was 48.7%, a significant, nearly threefold
improvement over the original ICCPS tool. False positive systemic inflammatory response
syndrome identifications were nearly sixfold lower.
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INTRODUCTION
BACKGROUND
Pediatric severe sepsis is a serious condition with worldwide sig-
nificance. Severe sepsis (SS) is defined as acute organ dysfunction
(OD) in the presence of sepsis; the latter refers to the presence
of a systemic infection, which can result from a bacterial, viral,
or fungal source. SS is a leading cause of multiple organ failure
and mortality across intensive care units (1). In the United States,
there are an estimated 751,000 cases/year with an annual cost of
$17 billion (1–5). Between 20,000 and 40,000 US children develop
septic shock annually, and its incidence is rising (6, 7).
Despite basic and clinical research efforts, SS and septic shock
mortality remain largely unchanged over the past 20+ years, rang-
ing from 23 to 50% (8, 9). To improve SS-related mortality, several
organizations published evidence-based guidelines for the man-
agement of SS and septic shock (8, 10, 11). These guidelines
Abbreviations: AUC, area under the curve; ECMO, extracorporeal membrane oxy-
genation; ED, emergency department; EMR, electronic medical record; GSSS, “gold
standard” severe sepsis (or septic shock); HR, heart rate; ICCPS, international con-
sensus conference on pediatric sepsis; NPV, negative predictive value; OD, acute
organ dysfunction; P25, 25th percentile (or first quartile); P75, 75th percentile
(or third quartile); PDSA, plan-do-study-act; PPV, positive predictive value; ROC,
receiver operating characteristics; RR, respiratory rate; SAS®, statistical analysis sys-
tem (SAS Institute Inc., Cary, NC, USA); SBP, systolic blood pressure; SCD, sickle
cell disease; SE, standard error; SIRS, systemic inflammatory response syndrome;
SS, severe sepsis.
provide a comprehensive bundle of recommended therapies for
clinicians that if effectively implemented, could improve patient
outcomes and reduce death. These guidelines include several time-
sensitive interventions, such as antibiotic administration and fluid
resuscitation, emphasizing the importance of early recognition of
shock and sepsis (12). Although a recent study questioned the
utility of such “early goal-directed therapy” (EGDT) measures for
adult septic shock cases, the importance of early detection and
initiation of antibiotic therapy nevertheless remains unchallenged
(13). Moreover, detection of SS in children is often more difficult at
least in part because of their greater ability to compensate during
early stages of septic shock (14).
IMPORTANCE
Presently, the diagnosis of SS (which will henceforth be under-
stood to also include cases that progressed to septic shock) is
highly dependent on the clinical acumen of the caregiver and thus
potentially subject to error. Creating an effective screening tool for
children is challenging because vital signs [i.e., heart rate (HR),
respiratory rate (RR), and blood pressure] and some laboratory
values are age-dependent. While effective SS screening tools have
been created for adults (15) and a proposed set of consensus-
derived guidelines for a pediatric SS screening tool was published
by the International Consensus Conference on Pediatric Sepsis
(ICCPS) (2, 16), a similar validated tool of high predictive value
for children has yet to be developed. Moreover, our preliminary
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testing of a screening tool based on the ICCPS guidelines resulted
in high numbers of false positive SS alerts that could lead to“trigger
fatigue” in a pediatric emergency department (ED) setting.
GOALS OF THIS INVESTIGATION
Beginning with the recommended components of a SS screen-
ing tool and age-specific criteria for vital signs put forth by ICCPS,
we empirically identified new vital sign thresholds and applied our
tool refinement methodology to create an improved tool for detec-
tion of SS in terms of specificity, positive predictive value (PPV),
and median time from patient arrival to SS detection. Although the
tool was refined using retrospective patient data, our goal is to cre-
ate an automated, real-time electronic version of the tool that will
be incorporated into the hospital electronic medical record (EMR)
and will actively screen all patients arriving at the pediatric ED.
MATERIALS AND METHODS
STUDY DESIGN AND SETTING
Our study refined and tested an electronic screening tool for pedi-
atric SS initially based on the ICCPS criteria. The refinement
process utilized a retrospective database containing demographic,
episode of care, and clinical data for all pediatric patients who
visited the ED of a large, metropolitan children’s hospital over a
2-month period. The collected data spanned the entire hospital
encounter of each patient, regardless of whether this involved only
an ED visit or continued as an observation or inpatient admission
to the hospital.
Although based upon retrospective data, the screening tool
evaluated the data for each case in chronological order in a manner
that emulated the function of a real-time tool, allowing the tool to
“fire” – indicating that the criteria for SS were met – at any time
during the simulated episode of care for that patient. The tool’s
determination of a case as “positive” or “negative” for SS was then
compared with an independent “gold standard” evaluation based
on physician chart review and coded discharge diagnoses.
An important component of our screening tool is the identifi-
cation of abnormal values for HR and RR in patients arriving at
the pediatric ED. Previous attempts to establish age-specific ranges
of normal and abnormal HR and RR, such as those suggested by
ICCPS, employed consensus values based on small numbers of
healthy, resting children and may not be appropriate for children
presenting to an ED. A recent study (17) suggested that empiri-
cally derived upper thresholds of normal HR and RR in pediatric
inpatient hospital settings are considerably higher than these pre-
viously used consensus values. Similarly, our study included an
empirical analysis of initial ED triage vital signs from over 140,000
children in order to derive age-specific values for normal and
abnormal HR and RR in a pediatric ED setting. The resulting rede-
finition of age-specific abnormal vital sign values for pediatric ED
patients was an essential precursor in the subsequent refinement
process that sought to create a screening tool with substantially
improved performance.
The evaluation and refinement of our pediatric SS screening
tool utilized virtual plan-do-study-act (PDSA) cycles with the goal
of optimizing the tool’s receiver operating curve (ROC) charac-
teristics – sensitivity, specificity, PPV, and area under the curve
(AUC) – while simultaneously attempting to minimize the time
from patient arrival to detection of children identified as genuine
cases of SS.
SELECTION OF PARTICIPANTS
The primary study group consisted of all pediatric patients aged
<18 years (N = 7,402) who presented to the ED of Le Bonheur
Children’s Hospital (Memphis, TN, USA) during January and
February, 2011. We refer to this group as the “Screening Tool
Refinement Group.”
A second, independent group of all pediatric patients aged
<18 years (N = 143,603), who presented to the ED of the Chil-
dren’s Hospital of The King’s Daughters (Norfolk, VA, USA)
between May, 2009 and September, 2012 and had electronically
recorded measurements of HR, RR, and temperature taken at the
time of triage, were selected in order to ascertain age-specific “nor-
mal” and “abnormal” values for HR and RR for pediatric patients
in a hospital ED setting. We refer to this group as the “Vital Signs
Standardization Group.” Various values for empirically derived
normal and abnormal HR and RR from the Vital Signs Standard-
ization group were then tested for their ROC performance using
the patient data from the Screening Tool Refinement group in the
ongoing tool refinement process.
The Screening Tool Refinement component of our study was
approved by the Institutional Review Board (IRB) at Le Bonheur
Children’s Hospital, and the Vital Signs Standardization compo-
nent was approved by the IRB at Eastern Virginia Medical School
(Norfolk, VA, USA).
METHODS AND MEASUREMENTS
Screening tool refinement group
Specific data elements of the EMR over the course of each patient’s
hospital encounter were obtained from the hospital’s Cerner data-
base using the PowerInsight® data extraction tool (Cerner Corpo-
ration, Kansas City, MO, USA). Data elements included the fol-
lowing: (1) patient characteristics and demographics; (2) episode
of care information (admission and discharge dates and times for
each hospital unit visited); (3) vital signs and clinical assessments;
(4) details regarding the use of supplemental oxygen, mechanical
ventilation, extracorporeal membrane oxygenation (ECMO), and
emergency resuscitation events; (5) laboratory tests and results;
(6) information on administered medications (asthma or seizure
drugs, vasoactive agents, beta blockers, and clonidine); and (7)
patient history as entered during ED triage.
An electronic screening tool for pediatric SS was designed using
SAS® (v 9.3) (SAS Institute Inc., Cary, NC, USA) programing
language. The tool algorithm, which determined if and when a
positive firing occurred in each case, was based on the published
ICCPS criteria, which were modified slightly to accommodate the
availability of data from the patients’ EMR. The criteria employed
in this initial version of the tool are summarized in Figure 1 (2,
16, 18–20).
To provide an independent assessment of the tool’s perfor-
mance, systematic physician chart reviews – with the goal of
identifying cases as positive or negative for SS – were performed
on all cases in the Screening Tool Refinement group that met one
of the following criteria: (1) a coded discharge diagnosis of one or
more of: “severe sepsis” or “septic shock;” a disseminated bacterial,
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FIGURE 1 | Initial severe sepsis screening tool based on ICCPS (2) criteria.
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fungal, or viral infection; or a localized infection or related con-
dition having the potential for progression to sepsis (see Table 1,
which lists the specific ICD-9-CM coded diagnoses selected for
chart review); or (2) a positive identification of SS (i.e., a “firing”)
by the version of the tool being tested. A total of 480 cases met one
or more of the above criteria and were selected for chart review. For
each instance of chart review, the reviewing physician searched for
evidence of SS, defined below as the presence of infection accom-
panied by systemic inflammatory response syndrome (SIRS) and
OD, and was blinded as to the tool’s independent assessment of the
case. For indeterminate cases, the final determination was made
by joint physician review conducted by two physicians. The final
result of this review process was the identification of “gold stan-
dard” SS cases that served as the standard for the assessment and
refinement of the tool.
Vital signs standardization group
The following data elements were obtained from the electronic
triage vital signs for each ED patient: HR, RR, body temperature,
and site of measurement, age, time between arrival and initial
vital signs measurement, and reason for visit. HR’s outside the
range of 30–300 beats/min, RR’s >120 breaths/min, and tempera-
tures outside the range of 33–43°C (or 32–43°C if axillary) were
rejected as spurious. Also rejected were HR’s and RR’s without a
corresponding temperature measurement needed for calculation
of temperature corrections of these rates.
OUTCOMES
The primary outcomes for the Screening Tool Refinement group
were the ROC values that describe the tool’s predictive ability
relative to the “gold standard” identification of SS by physician
Table 1 | List of ICD-9-CM (21) coded diagnoses selected for chart review.
A. DISSEMINATED INFECTIONS
003.1 Salmonella septicemia 771.81 Septicemia (sepsis) of the newborn
018.xx Miliary tuberculosis 771.83 Bacteremia of the newborn
020.2 Septicemia plague 785.52 Septic shock
022.3 Anthrax septicemia 790.7 Bacteremia
031.2 Disseminated mycobacteremia 790.8 Viremia, unspecified
036.2 Meningococcemia 995.90 Systemic inflammatory response syndrome (SIRS)
038.xx Septicemia
040.82 Toxic shock syndrome 995.91 Sepsis
054.5 Herpetic septicemia 995.92 Severe sepsis
084.x Malaria 999.31 Other and unspecified infection due to central venous catheter
098.89 Gonococcemia
112.5 Disseminated candidiasis 999.32 Bloodstream infection due to central venous catheter
130.8 Multi-systemic disseminated toxoplasmosis
999.34 Acute infection following transfusion, infusion, or injection of
blood and blood products
415.12 Septic pulmonary embolism
449 Septic arterial embolism
670.2 Major puerperal infection 999.39 Infection following other infusion, injection, transfusion, or
vaccination670.3 Puerperal septic thrombophlebitis
B. LOCALIZED INFECTIONS AND ASSOCIATED CONDITIONS
079.99 Unspecified viral infection 570 Acute and sub-acute necrosis of liver
276.2 Acidosis 573.9 Unspecified disorder of liver
286.x Coagulation defects 593.9 Acute renal insufficiency
320.xx Bacterial meningitis 681.xx Cellulitis and abscess of finger and toe
321.x Meningitis due to other organisms 682.x Other cellulitis and abscess
322.9 Meningitis unspecified 728.86 Necrotizing fasciitis
421.x Acute and sub-acute endocarditis 777.5x Necrotizing enterocolitis in newborn
422.xx Acute myocarditis 777.6 Perinatal intestinal perforation
480.x Viral pneumonia 780.0 Alteration of consciousness
481 Pneumococcal pneumonia 780.2 Syncope and collapse
482.xx Other bacterial pneumonia 780.4 Dizziness and giddiness
483 Pneumonia due to other unspecified organism 868.1x Injury to intra-abdominal organs: with open wound into cavity
484.x Pneumonia in infectious disease classified elsewhere 869.1 Internal injury to unspecified or ill-defined organs: with open
wound into cavity
485 Bronchopneumonia, organism unspecified 996.6x Infection and inflammatory reaction to internal prosthetic device,
implant, graft486 Pneumonia, unspecified
557.0 Vascular insufficiency of the intestine
567.0 Peritonitis and retroperitoneal infections 998.59 Other postoperative infection
567.1 Pneumococcal peritonitis
567.2x Other suppurative peritonitis
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chart review: sensitivity (and percentage of false negatives), speci-
ficity (and percentage of false positives), PPV, negative predictive
value (NPV), and AUC. Given that the tool was designed to be
incorporated into an automated, electronic screening tool that
would run in the background for all patients entering the pedi-
atric ED, our ROC test denominator consisted of all ED patient
arrivals, since the possibility of a false negative or false posi-
tive result exists for all patients screened by the tool. Because
ICCPS defined “sepsis” as the presence of infection accompa-
nied by SIRS, and “severe sepsis” as sepsis accompanied by OD,
the tool was designed to include both a SIRS and an OD com-
ponent. We therefore added, as a secondary outcome, the per-
centage of cases that fired the SIRS component of the tool,
which may be used to screen for the presence of sepsis in the
absence of OD. Additionally, we included as a secondary out-
come the median time from patient arrival to tool firing (in cases
where firing occurred), which acts as a balancing measure for
the purpose of weighting tool accuracy against the need for early
identification of SS.
For the Vital Signs Standardization group, age-dependent
(using the age intervals adopted by ICCPS) means and upper
thresholds of normal (calculated as means plus a specified num-
ber of standard deviations) for HR and RR were determined. This
methodology followed the original ICCPS criteria for upper limits
of normal HR and RR, which were defined as the respective age-
specific values of “mean+ 2 SD.” Additionally, upper thresholds
were calculated as “temperature corrected to 37°C” using both lin-
ear (22, 23) and exponential (24, 25) models for the temperature
dependence of HR and RR. Linear temperature corrections were
of the form: Corrected Rate (HR or RR)=Raw Rate− (C×∆T),
where C is a fixed number of beats/min or breaths/min, and
∆T= (Body Temperature −37.0°C). Exponential temperature
corrections were of the form: Corrected Rate = Raw Rate÷Q∆T1 ,
where Q1 is the proportional increase in rate for a 1°C increase in
temperature, and∆T is as defined above.
ANALYSIS
Vital signs standardization
Analysis of the relationship of HR and RR with body temperature
by age category led to the creation of exponential models that were
used to derive a set of temperature corrected means and arbitrary
upper thresholds of normal (mean+ 2 SD, mean+ 2.2 SD, etc.)
HR and RR for each age category. Similar sets of corrected means
and upper thresholds were also derived on the basis of temperature
corrections suggested by previous studies. Ultimately, the choices
of standards for abnormal HR and RR were based on each model’s
plausibility and empirical ability to optimize the performance of
the screening tool.
Screening tool refinement
Univariate analyses were performed for each measure incorpo-
rated into the screening tool to assess the association of abnormal
values of that measure with gold standard identified SS. Addition-
ally, the strengths of these associations at the time of the initial
firing of the screening tool were compared with the respective
associations looked at cumulatively throughout each patient’s hos-
pital encounter. This allowed us to define abnormal values of
particular metrics as “early” (i.e., commonly present at the initial
firing of the tool) or“late”(i.e., not commonly present initially, but
rather at some later time during the disease progression) indica-
tors of SS. For both the early and late measures of association, the
statistical significance of each association was determined using
an exact chi-square test.
Refinement of the tool was accomplished through virtual PDSA
cycle iterations, with the goal of successively improving ROC val-
ues with minimal increase in the mean interval between patient
arrival and tool firing for Gold Standard SS cases. Using AUC as
the measure of overall tool performance, the significance of our
tool refinement process was evaluated using a chi-square test of
the paired comparison between the original ICCPS (2) based tool
and our final, revised tool (26).
To test whether the performance of our final tool was general-
izable, we utilized a split-sample validation technique whereby
the results from cases representing the Screening Tool Refine-
ment group’s first month of patient arrivals were compared with
cases representing the second month of arrivals. AUC was again
selected as the measure of overall tool performance, and the differ-
ence in AUC for the two subsets was evaluated using an unpaired
t -test (26).
RESULTS
CHARACTERISTICS OF STUDY SUBJECTS
Vital signs standardization group
A summary of the vital signs data for the Vital Signs Standard-
ization group is shown in Table 2. Applying these standards to
redefine tachycardia and tachypnea, using the ICCPS criteria of
>2 SD above the mean for each age group, resulted in markedly
higher thresholds than those published by ICCPS.
Screening tool refinement group
Some general characteristics of the Screening Tool Refinement
group are listed in Table 3. Notably, inspection of Gold Standard
SS cases identified by physician chart review revealed that <20%
of all SS cases were actually identified as such by discharge cod-
ing, with the remainder being “under-coded” with a less severe
diagnosis. Moreover, over 20% of these SS cases had negative cul-
ture results for infectious organisms (bacteria, viruses, or fungi)
in blood, CSF, or urine, and about 10% of the cases had negative
respiratory culture results as well. Additionally, while overall mor-
tality was quite low (8/7,402, or 0.1%) among the children who
visited the ED during the 2-month study period, nevertheless 38%
of these deaths (three out of eight) occurred among the children
identified as Gold Standard SS cases. In a large majority of Gold
Standard SS cases, the patient did not arrive at the ED in a con-
dition of SS but rather progressed to that condition during the
course of the hospital stay. This is consistent with our finding that
the median time from patient arrival to initial tool firing for these
cases was 11.1 h, with the 25th and 75th percentiles firing at 5.0
and 22.2 h, respectively.
MAIN RESULTS
Vital signs standardization
Based on their empirical utility in identifying Gold Standard SS
cases, the age-specific thresholds for tachycardia and tachypnea
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Table 2 | Characteristics of pediatric vital signs standardization group (N =143,603)a.
Age category Heart rate Respiratory rate Body temperatureb
N Mean
(beats/min)
SD N Mean
(breaths/min)
SD N Mean (°C) SD
Neonatec (0–4 weeks) 2,681 153.3 19.3 2,626 42.2 9.3 2,709 37.1 0.5
Infant (>4 to <2 years) 45,418 141.8 23.0 44,707 32.1 9.3 46,121 37.5 1.0
Toddler and preschool (2 through 5 years) 43,240 121.4 22.7 42,384 24.4 6.8 43,826 37.2 0.8
School age child (6 through 12 years) 34,229 100.5 20.5 33,472 21.8 5.2 34,550 37.0 0.8
Adolescent and young adult (13 to <18 years) 16,216 88.2 18.9 15,949 19.5 4.5 16,397 36.8 0.6
aThis represents the number of cases with measurements of body temperature and either (or both) heart rate or respiratory rate.
bTemperatures collected via the axillary route were corrected by adding 0.2°C for neonates, and 0.6°C for all other age categories (18, 27).
cCombines the “newborn” and “neonate” categories as defined by ICCPS (2).
Table 3 | Characteristics of screening tool refinement group (N =7,402).
Characteristics Mean (SD) or % (N )
Age category 5.9 years (5.5)
Neonatea (0–4 weeks) 2.5% (184)
Infant (>4 weeks to <2 years) 33.1% (2,452)
Toddler and preschool (2 through 5 years) 25.3% (1,873)
School age child (6 through 12 years) 22.2% (1,640)
Adolescent and young adult
(13 to <18 years)
16.9% (1,253)
Gender
Male 54.8% (4,056)
Female 45.2% (3,346)
Admitted as inpatient 21.1% (1,561)
Coded as severe sepsis or septic shock at
discharge
0.1% (7)
Total severe sepsis/shock (by physician review) 0.5% (38)
Among age groups: neonatea (N =184) 1.6% (3)
Infant (N =2,452) 0.6% (15)
Toddler and preschool (N =1,873) 0.4% (7)
School age child (N =1,640) 0.3% (5)
Adolescent and young adult (N =1,253) 0.6% (8)
Severe sepsis/shock cases with negative blood,
CSF, and urine (B/C/U) cultures
21.2% (8/38)
Severe sepsis/shock cases with negative B/C/U
and respiratory cultures
10.5% (4/38)
Median length of stay among severe
sepsis/shock cases (days)
14.5 (Range: 0.7–78.7)
Overall mortality (all causes) 0.1% (8)
Mortality among severe sepsis/shock cases
(N =38)
7.9% (3)
aCombines the “newborn” and “neonate” categories as defined by ICCPS (2).
were selected using models employing a linear temperature cor-
rection to derive standardized HR’s and RR’s corrected to 37°C.
For HR, the model assumed a fixed increase of 10 bpm/°C of
temperature increase, as proposed by Davies and Maconochie
(22). Similarly, for RR the model used a fixed increase of
7 breaths/min °C for neonates (which also includes the original
ICCPS category “newborn”) and infants; and 5 breaths/min °C for
all other age groups, as proposed by Gadomski et al. (23). The final
optimized temperature corrected thresholds, representing mean
HR +2.2 SD and mean RR +2.8 SD for each age category, are
shown in Figure 2 (2, 18–20, 22, 23, 27–29).
Screening tool refinement
Univariate associations of SIRS and OD metrics with gold stan-
dard SS. The results of univariate analyses of the associations of
individual SIRS and OD metrics with physician identified Gold
Standard SS cases are shown in Table 4. Among SIRS measures
[HR, RR, temperature, white blood cell (WBC) count, and neu-
trophil percent banding], the strongest associations – defined as
the ratio (relative risk) of the incidence of cases with ≥1 abnor-
mal value of that measure among Gold Standard SS cases to that
among non-Gold Standard SS cases – were found for temperature
corrected HR and RR, with ratios of 13.8 and 9.6, respectively.
This finding led us to redefine the tool’s criteria for a positive find-
ing of SIRS from the original ICCPS definition (which required
abnormal values for two SIRS components, one of which must
be temperature, WBC count, or neutrophil percent banding) to
a more restrictive definition that additionally requires the second
abnormal SIRS component to be either HR or RR. In terms of tool
performance, this redefinition allowed us to markedly improve
overall specificity without any loss in sensitivity.
The univariate analyses also allowed us to identify certain SIRS
and OD component measures as “early” indicators of SS (i.e.,
exhibiting abnormal values in a majority or near-majority of gold
standard SS cases at the initial firing of the screening tool), or as
“late” indicators (i.e., exhibiting abnormal values in a minority of
Gold Standard SS cases at the time of initial tool firing, but in a
majority or near-majority of Gold Standard SS cases at some later
time during the patients’ hospital encounters). These findings are
summarized in Table 4.
Several measures incorporated into the original ICCPS based
tool were found to have a very low incidence among Gold Standard
SS cases or to have an association that was not statistically signifi-
cant. Specifically, a very small percentage of Gold Standard SS cases
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FIGURE 2 | Final, revised pediatric severe sepsis screening tool.
w
w
w
.fro
n
tiersin
.o
rg
June
2014
|Volum
e
2
|A
rticle
56
|7
                                                         
S
epanskiet
al.
Pediatric
severe
sepsis
screening
tool
Table 4 | Association of severe sepsis with abnormal SIRS and OD metrics.
Measure Association based on cases having ≥1 abnormal value Association based on cases having ≥1 abnormal value
at time of initial tool firing at any time during hospital encounter
% Of gold Relative Total p Early % Of gold Relative Total p Late
standard sepsis risk of ≥1 number of indicator standard sepsis risk of ≥1 number of indicator
cases with abnormal patients of severe cases with abnormal patients of severe
≥1 abnormal valuea measured sepsisb ≥1 abnormal valuea measured sepsisc
value or tested value or tested
Temp. or WBC count or % banding 100 4.0 7, 377 <0.0001 X 100 4.0 7,377 <0.0001
Temp. corrected HR or RR 97.4 9.7 7,392 <0.0001 X 97.4 9.7 7,392 <0.0001
Temp. corrected HR 81.6 13.8 7,392 <0.0001 X 84.2 14.2 7,392 <0.0001
Temperature 67.6 3.4 7,369 <0.0001 X 84.2 4.3 7,370 <0.0001
Temp. corrected RR 60.5 9.6 7,390 <0.0001 X 89.5 14.0 7,390 <0.0001
Neutrophil % banding 59.3 3.2 358 <0.0001 X 61.3 3.2 364 <0.0001
Use of mechanical ventilation 57.9 137.5 7,402 <0.0001 X 68.4 157.5 7,402 <0.0001
White blood cell (WBC) count 55.6 1.8 2,033 0.003 X 78.4 2.5 2,036 <0.0001
Prothrombin time (PT)/INR 50.0 25.9 273 <0.0001 X– 47.1 24.4 276 <0.0001
ALT or AST level 42.3 6.4 1,147 <0.0001 X– 45.7 6.9 1,157 <0.0001
Systolic blood pressure 42.1 13.6 7,337 <0.0001 X– 65.8 21.0 7,337 <0.0001 X
CNS function 39.4 10.4 7,326 <0.0001 60.5 15.9 7,332 <0.0001 X
Peripheral pulse strength (weak) 34.3 73.1 6,857 <0.0001 50.0 106.6 6,860 <0.0001 X–
Lactate 33.3 2.5 65 0.19 19.0 1.4 74 0.50
Base deficit 32.0 2.5 285 0.02 48.5 3.9 296 <0.0001 X–
Lactate+base deficit 27.3 2.8 52 0.15 19.0 2.0 62 0.43
Capillary refill time 25.7 13.0 7,139 <0.0001 47.4 24.0 7,142 <0.0001 X–
Use of supplemental O2 w/o vent 23.7 12.9 7,402 <0.0001 55.3 29.3 7,402 <0.0001 X
Use of vasoactive agents 13.2 242.2 7,402 <0.0001 31.6 465.1 7,402 <0.0001
Creatinine 11.8 31.6 1,917 <0.0001 10.8 29.1 1,922 <0.0001
Platelet count 8.8 7.9 2,012 0.008 24.3 21.0 2,018 <0.0001
Bilirubin 3.8 2.3 1,118 0.36 8.6 5.2 1,128 0.02
aCalculated as the ratio of the incidence of cases with ≥1 abnormal value of the measure among gold standard severe sepsis (GSSS) cases to the incidence among non-GSSS cases.
bMeasures for which >50% of gold standard severe sepsis cases exhibit abnormal values at the time of initial tool firing are denoted as stronger early indicators of severe sepsis with the symbol “X.” Measures
for which 40–50% of gold standard severe sepsis cases exhibit abnormal values at the time of initial tool firing are denoted as weaker early indicators of severe sepsis with the symbol “X–.”
cMeasures for which <50% of gold standard severe sepsis cases exhibit abnormal values at the time of initial tool firing and >50% of gold standard severe sepsis cases exhibit abnormal values at any time during
the hospital encounter are denoted as stronger late indicators of severe sepsis with the symbol “X.” Measures for which <40% of gold standard severe sepsis cases exhibit abnormal values at the time of initial
tool firing and 40–50% of gold standard severe sepsis cases exhibit abnormal values at any time during the hospital encounter are denoted as weaker late indicators of severe sepsis with the symbol “X–.”
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showed abnormal bilirubin (3.8% at initial tool firing, p= 0.36;
8.6% at any time during the patient encounter, p= 0.02), and the
association of abnormal lactate – either alone or in combination
with abnormal base deficit – with Gold Standard SS was not sta-
tistically significant (lactate alone: p= 0.19 at initial tool firing,
and p= 0.50 cumulatively during the encounter; lactate+ base
deficit: p= 0.15 initially, and p= 0.43 cumulatively). However,
the absence of an association of Gold Standard SS with lactate
may reflect the small number of instances that lactate tests were
ordered (N = 65 initially, and N = 74 cumulatively) for patients
in the Screening Tool Refinement group.
Tool refinement process
A summary of the changes to the original ICCPS criteria lead-
ing to our final pediatric SS screening tool is given in Table 5.
These changes were generally classifiable into three categories: (1)
the addition of new criteria to improve tool sensitivity; (2) the
removal or modification of criteria to improve tool specificity;
and (3) the use of patient history (triage) information or medica-
tion administration data to identify classes of conditions – such
as asthma, seizures, diabetic ketoacidosis, and sickle-cell disease
(SCD) – that were likely to cause false positive tool firing, and to
suppress the firing of portions of the tool for these patients.
The criteria incorporated in the final revised version of our tool
are shown in Figure 2. A comparison of the previously described
primary and secondary outcome measures for the initial ICCPS
and final revised screening tools is given in Table 6, showing that
the PPV increased from 14.6% in the original tool to 48.7% in
the final tool – a more than threefold improvement – while main-
taining the same high sensitivity (97.4%) in both versions. This
improvement was highly significant (p< 0.0001) in terms of the
paired comparison of AUC between the two versions of the tool.
Simultaneously, the percentage of children meeting SIRS criteria
was reduced from 23.9 to 4.3%, a nearly sixfold improvement.
Because all firings of the full tool (SIRS+OD) also represent
SIRS firings, this decrease in SIRS firings in the absence of any
decrease in full tool sensitivity implies that these additional firings
in the original version were false positives from the perspective of
a SS screening tool. The overall reduction of false positive firings
for both the SIRS component of the tool and the overall SS tool
(SIRS+OD) is illustrated in Figure 3.
Validation
The split-sample validation analysis tested the null hypothesis that
the AUC for the results from the first month of Screening Tool
Refinement group patient data did not differ from that for the
second month. The relevant ROC outcomes for the two data sub-
sets were as follows: month (#1) N = 3,713, sensitivity= 96.0%,
specificity= 99.5%, AUC= 0.9774, standard error (SE)= 0.02;
month (#2) N = 3,689, sensitivity= 100%, specificity= 99.5%,
AUC= 0.9973, and SE= 0.0006. The resultant AUC difference of
0.0199 was not statistically significant (p= 0.32), thus confirming
that the tool outcomes were generalizable over the two indepen-
dent study sub-samples.
LIMITATIONS
The Screening Tool Refinement group consisted of 7,402 cases,
representing 2 months of ED visits at a single children’s hospital.
Among this group, 38 cases of Gold Standard SS were identified.
A larger study population drawn from multiple children’s hospi-
tals and with more Gold Standard SS cases would be desirable.
However, a principal strength of our methodology lay in its estab-
lishment of a “gold standard” identification of SS cases based on
physician chart review of 480 patient cases that was consistent
across the study group and independent of the appraisal of the
screening tool. While it may be argued that a true gold standard
determination should involve chart reviews of all 7,402 cases, such
a procedure is not practical, especially given that the next step
in tool validation would involve the expansion of the study to a
much larger patient population. In an attempt to review all cases
having some likelihood to be instances of SS, we employed a very
wide diagnostic “net” that included all cases that fired the tool, all
cases with a diagnosis of any disseminated infection (including
but not limited to septic shock, SS, and sepsis), additional cases
with a coded localized infection that has been known to progress
to sepsis, and even cases with coded symptoms of organ dysfunc-
tions (including hepatic, renal, CNS, and metabolic) likely to be
present in patients with SS. We believe it very unlikely that a case
of SS would escape inclusion by this net, and we note that other
published validations of adult sepsis tools, such as that of Moore
et al. (15), have employed a much narrower net. The latter study,
for example, selected only cases that fired the tool or had a coded
diagnosis of a disseminated infection for inclusion in the chart
review process to determine gold standard sepsis status.
As stated earlier, our objective was to create an improved tool
for detection of SS in terms of specificity, PPV, and median time
from patient arrival to SS detection. We recognize that the attempt
to create an “optimized” tool involves a trade-off; for example, it
was possible to create a tool with a shorter median time to sep-
sis detection at the cost of a considerable decrease in specificity.
Our initial SS screening tool based on the original ICCPS criteria
proved to be quite sensitive but not very specific, which would
likely lead to trigger fatigue in an ED setting. Our approach was to
prioritize high specificity while minimizing (but not eliminating)
an inevitable increase in median time to sepsis detection. Thus, for
example, our final tool suppresses firing based on abnormal HR,
RR, and respiratory organ dysfunction for the first hour following
patient arrival in order to allow entry of additional information
that may identify such patients as having non-septic conditions
such as asthma, seizure, or SCD. This suppression of firing resulted
in an increase in the first quartile time to sepsis detection by the
tool among gold standard cases by 1.7 h (from 3.3 h without sup-
pression to 5.0 h with suppression). However, it also decreased
the number SIRS firings among non-Gold Standard SS cases by
26%, from 377 to 278 over the 2-month study period, without
decreasing the sensitivity of the tool in identifying cases of SS.
Other significant limitations resulted from the retrospective
nature of our study; consequently, the scope of our data capture
was restricted to patient information and tests taken or ordered at
a time before a specific sepsis protocol was in place at the Screen-
ing Tool Refinement study hospital. In particular, our ability to
assess the association between Gold Standard SS and lactate or
neutrophil percent banding was limited by the infrequent ordering
of these tests. Similarly, our ability to determine the association of
Gold Standard SS with peripheral pulse strength or capillary refill
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Table 5 | Alterations/revisions made to the original ICCPS (2) version of the pediatric severe sepsis tool.
Respiratory organ dysfunction (OD): cases not requiring mechanical ventilation but meeting the PEARS 2012 criteria (29) for respiratory dysfunction
(FiO2 >50% with oxygen saturation >90 and <94%), or having two successive oxygen saturations ≤90%, were redefined as minor respiratory OD and
required a second minor OD to trigger the full OD component of the tool. FiO2 was estimated using EMR entries of O2 flow rate and an estimate of tidal
volume based on age, weight, and gender (19)
Axillary temperatures: a correction of +0.6°C for non-neonates (18), and +0.2°C for neonates (27), was added to temperature measurements made via
the axillary route
Asthma and seizures: abnormal values for HR, RR, and respiratory OD were suppressed for 2 h following administration of asthma medications
[albuterol, dexamethasone, epinephrine (intramuscular or subcutaneous), methylprednisolone, magnesium sulfate, or terbutaline] or seizure medications
(lorazepam, levetiracetam, fosphenytoin, or phenobarbital)
First hour HRs, RRs, and respiratory OD: tool specificity was improved by suppressing abnormal values for HR and RR, and the respiratory OD
component of the tool, for the first hour after patient arrival. This also allowed for the identification and treatment of asthmatic and seizure patients.
Importantly, tool sensitivity and median time from patient arrival to detection of severe sepsis were unaffected
CNS OD was dropped from the tool, improving specificity without affecting sensitivity
Abnormal prothrombin time (PT) was added as an additional indicator of hematologic OD alongside INR, resulting in improved tool sensitivity
Bilirubin was dropped as a measure of hepatic OD due to its very weak association with pediatric severe sepsis
Peripheral pulse strength was dropped as a “Minor” measure of cardiovascular OD, improving specificity without affecting sensitivity
Data entry error detection algorithms were added to drop unreasonable values for vital signs, systolic blood pressures (SBP’s) that represented extreme
drops from their previous readings, and vital signs with two or more disparate values having identical recorded date and time values. This was necessary
to overcome difficulties inherent in the application of the tool to systems that utilize electronic medical records
Sickle-cell disease (SCD): abnormal WBC count values and minor respiratory OD triggers were suppressed for patients with an entered history of SCD,
improving tool specificity. The suppression of abnormal WBC count for this group followed from finding that roughly 50% of SCD patients exhibited
abnormally high WBC counts in the absence of severe sepsis
Diabetes: abnormal base deficit readings were suppressed for all patients for the first 2 h after arrival and for patients administered insulin or with an
entered history of diabetes. This allowed for the identification and treatment of patients with diabetic ketoacidosis
Abnormal AST level was added as an additional indicator of Hepatic OD (the original tool considered only ALT), resulting in improved sensitivity
Ventilator dependence, as identified and entered at triage, resulted in a suppression of the respiratory OD trigger for these patients, improving tool
specificity
“SBP2”: the PALS criteria for systolic hypotension (28) were substituted for those given in the ICCPS 2005 supplement (16). This increased the
specificity of the tool modestly from versions employing the latter criteria, and greatly from versions employing the SBP criteria given in the original
ICCPS 2005 guidelines (2)
Lactate was restricted as a “Minor” indicator of cardiovascular OD to cases where elevated lactate was accompanied by abnormal base deficit, i.e.,
acidosis
Redefinition of abnormal HR and RR: the set of empirically derived cut-offs defining tachycardia and tachypnea, derived from our Pediatric Vital Signs
Standardization Group, were substituted for those given in the original ICCPS guidelines
“SIRS2”: the criteria for triggering the SIRS component of the tool were redefined to require one abnormal value of either temperature, WBC, or
neutrophil banding; and one abnormal value of either HR or RR
Temperature corrections of HR and RR were added, based on the linear relationships reported by Davies and Maconochie (22), and Gadomski et al.
(23), respectively. Together with the redefinition of abnormal HR and RR, and the redefinition of criteria for SIRS, this resulted in a substantial increase in
tool specificity with no loss of sensitivity
time was confounded by the documentation practice of assigning
default values of “Normal” to these measures unless specifically
noted otherwise, which removed the ability to distinguish between
cases where no actual measurement was taken (i.e., those with
missing values) and cases where a measurement was taken and
found to be normal.
Additionally, we were unable to assess CNS function among the
Screening Tool Refinement group using the preferred ICCPS mea-
sure, the Glasgow Coma Score, because that measure was seldom
utilized at the study hospital except for trauma cases. We there-
fore designed an alternative measure of CNS function based on
the Nursing Neurological Assessment in the Cerner EMR, which
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Table 6 | Comparison of initial and final versions of the pediatric severe sepsis screening tool.
Measure Original ICCPS (2) based tool Final revised tool
Total cases/gold standard severe sepsis (GSSS) cases 7,402/38 7,402/38
SIRS firingsa/percentage of total cases 1,772/23.9 315/4.3
False positives/false negatives 217/1 39/1
Sensitivity/specificity (%) 97.4/97.1 97.4/99.5
Positive predictive/negative predictive value (%) 14.6/99.99 48.7/99.99
Area under the curve (AUC) 0.972 0.984
Median time from arrival to tool firing for GSSS cases 10.3 h (P25=2.8, P75=20.6) 11.1 h (P25=5.0, P75=22.2)
aSIRS Firing indicates that the tool “detected” the presence of SIRS based on the criteria used by the tool.
FIGURE 3 | Comparison of ICCPS (2) based tool with final revised tool.
was recorded at triage and completed for nearly all patients in
the Screening Tool Refinement group. While this available EMR-
based assessment represented the best source of CNS function
appraisal available for our study group, our finding that CNS func-
tion measured in this manner is not a strong early indicator of
Gold Standard SS should not be generalized so as to discourage
the development of alternative measures of neurologic function
that may show a stronger association with Gold Standard SS.
DISCUSSION
The ICCPS guidelines represented a consensus derived from exist-
ing definitions and criteria for SS in adults that were extended
to pediatrics. Because its guidelines were the result of consensus,
ICCPS did not empirically derive screening tool criteria for SS
that optimized sensitivity, specificity, PPV, and time from patient
arrival to sepsis detection. With respect to vital signs, the tables
found in the original ICCPS document were based on data from
normal, healthy children obtained for purposes not related to the
optimal detection of SS.
Our methodology combined a retrospective, iterative method
of screening tool optimization, an empirically derived set of age-
specific thresholds for abnormal HR and RR, and an intensive
physician chart review process to establish a “gold standard” iden-
tification of SS. This resulted in a pediatric SS screening tool with
a PPV that is significantly higher than any previously published.
Furthermore, the high predictive value of our tool extended to
cases that did not show positive blood, CSF, urine, or respiratory
culture results – either for bacteria, viruses, or fungi – and so might
have escaped early detection by traditional methods that rely on
such positive culture results. The use of antibiotics prior to the
time when the cultures were obtained may have hindered bacte-
ria from growing in the various samples. Additionally, rapid viral
antigen tests are not inclusive of the many types of viruses that
may infect patients.
In addition to our tool refinement methodology and our
derivation of an improved set of age-specific vital signs thresholds,
our study resulted in several other improvements to the original
ICCPS components and criteria:
(1) Analysis and classification of ICCPS defined component mea-
sures of SIRS or OD as “early” or “late” indicators of SS
according to the association of abnormal values for each of
these measures with Gold Standard SS and to the time during
the hospital encounter with respect to initial tool firing when
these abnormal values occurred;
(2) Redefinition of SIRS in a way that ensures that those SIRS
components having the greatest association with Gold Stan-
dard SS – namely, temperature corrected values of HR or
RR – become mandatory criteria for the screening tool to
“detect” the presence of SIRS; and
(3) Consolidation of the ICCPS defined age categories “New-
born” and “Neonate,” which no longer require separate sets
of thresholds (with the sole exception of those for abnormal
WBC Count).
While we believe that our screening tool represents a significant
advancement in the prediction of SS in children, we also recognize
the need for continued work toward improved accuracy and time-
liness in its detection. One avenue for future investigation lies in
the reexamination of pediatric age categories, particularly those
chosen for vital signs thresholds. Given that a major challenge
in designing a SS tool for children is the age-specific nature of
what is “abnormal” for a given vital sign or laboratory result, we
believe that an optimal pediatric sepsis screening tool should be
based on empirically derived age categories of reasonable unifor-
mity in terms of thresholds for“abnormal”obtained from children
presenting to healthcare providers.
There is also a need for sepsis detection tools that alert clini-
cians to the likelihood of sepsis at an early point during a patient
encounter, even as early as the time of ED triage. Obviously,
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the development of such a triage sepsis screening tool presents
a unique challenge: the need to provide a reasonably sensitive and
specific prediction of sepsis in the absence of laboratory results,
and so based disproportionately on readily observed clinical signs,
vital signs, and patient history. With the goal of improving the
detection and treatment of pediatric sepsis – where each hour of
delay increases the risk of death – it remains a priority to con-
tinue our efforts to detect this disease more quickly, accurately,
and efficiently.
CONCLUSION
Our iterative, virtual PDSA cycle method of tool refinement,
empirically derived thresholds of abnormal HR and RR in an ED
setting, and independent, physician review-based identification of
“gold standard” SS cases resulted in a pediatric SS screening tool
for the ED having improved predictive value compared with that
of a tool derived from the original ICCPS (2) criteria.
Additionally, our analysis of component SIRS and OD met-
rics led to the identification of strong “early” indicators of SS.
In descending strength of association with Gold Standard SS,
these were: temperature corrected HR, temperature, temperature
corrected RR, neutrophil percent banding, need for mechanical
ventilation, and white blood count. Other SIRS and OD com-
ponent metrics, such as systolic blood pressure (SBP) and CNS
function, were also found to have a strong association with SS but
were identified as “late” indicators and so relatively less useful in
designing a tool whose goal is the timely detection of SS.
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